Thrombosis in primary myelofibrosis: incidence and risk factors

How I treat symptomatic splenomegaly in patients with myelofibrosis

(2009) R. A. Mesa   BLOOD

Advances in Understanding and Management of Myeloproliferative Neoplasms

(2009) A. M. Vannucchi et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Pomalidomide Is Active in the Treatment of Anemia Associated With Myelofibrosis

(2009) Ayalew Tefferi et al.   JOURNAL OF CLINICAL ONCOLOGY

Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: A systematic review

(2009) Federico Lussana et al.   THROMBOSIS RESEARCH

Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemia

(2008) A. Carobbio et al.   BLOOD

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

(2008) F. Cervantes et al.   BLOOD

Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients

(2008) F. Passamonti et al.   HAEMATOLOGICA

Evidence and expertise in the management of polycythemia vera and essential thrombocythemia

(2008) G Finazzi et al.   LEUKEMIA